In silico and in vitro investigation of bile salts as coformers for edaravone coamorphous dispersion- Part I-Reference-Cited by-同舟云学术

In silico and in vitro investigation of bile salts as coformers for edaravone coamorphous dispersion- Part I

Published:2023-07 Issue: Volume:253 Page:105302
ISSN:0009-3084
Container-title:Chemistry and Physics of Lipids
language:en
Short-container-title:Chemistry and Physics of Lipids

Author:

Patel Dhrumi,Wairkar Sarika^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Organic Chemistry,Molecular Biology,Biochemistry

Reference40 articles.

1. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines;Aburahma;Drug Deliv.,2016

2. Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system;Alhajj;Int. J. Pharm.,2022

3. Single-crystal investigation, hirshfeld surface analysis, and DFT study of third-order NLO properties of unsymmetrical acyl thiourea derivatives;Ashfaq;ACS Omega,2021

4. Density-functional exchange-energy approximation with correct asymptotic behavior;Becke;Phys. Rev. A,1988

5. Jaguar: a high-performance quantum chemistry software program with strengths in life and materials sciences;Bochevarov;Int. J. Quantum Chem.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manifesting the Dasatinib-gallic acid co-amorphous system to augment anticancer potential: Physicochemical characterization, in silico molecular simulation, ex vivo permeability, and in vitro efficacy;International Journal of Pharmaceutics;2024-11

2. Specific intermolecular interaction with sodium glycocholate generates the co-amorphous system showing higher physical stability and aqueous solubility of Y5 receptor antagonist of neuropeptide Y, a brick dust molecule;European Journal of Pharmaceutics and Biopharmaceutics;2024-09

3. Effect of food on oral pharmacokinetics of edaravone coamorphous dispersion containing bile salts as coformers – Part II;Annales Pharmaceutiques Françaises;2024-06